Intravenous immunoglobulin prevents experimental autoimmune myositis in SJL mice by reducing anti–myosin antibody and by blocking complement deposition

High-dose intravenous immunoglobulin (IVIG) therapy has been effective in many autoimmune and systemic inflammatory diseases including polymyositis (PM) and dermatomyositis (DM). In the present study we evaluated the efficacy of IVIG using experimental models of PM and DM. An experimental autoimmune...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Wada, J, Shintani, N, Kikutani, K, Nakae, T, Yamauchi, T, Takechi, K
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Blackwell Science Inc 2001
Gaiak:
Immunotherapy
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC1906047/
https://ncbi.nlm.nih.gov/pubmed/11422206
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1046/j.1365-2249.2001.01499.x
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak